New PET Scanning Probe From Modified Chemotherapy Drug Will Allow Monitoring Of The Immune System, University of California, Los Angeles (UCLA) Research

ScienceDaily — Researchers at UCLA’s Jonsson Comprehensive Cancer Center have modified a common chemotherapy drug to create a new probe for Positron Emission Tomography (PET), an advance that will allow them to model and measure the immune system in action and monitor response to new therapies.